Search





Search





UK's NuCana Q4 net loss widens

ReutersMar 19, 2026 8:25 PM

Overview

UK biopharma firm's Q4 net loss widened yr/yr
NuCana expects key clinical milestones for lead cancer drug NUC-7738 in 2026

Outlook

NuCana anticipates cash resources will fund operations into 2029

Result Drivers

NON-CASH FINANCE EXPENSE - Co said net loss for the year included £12.6 mln non-cash loss from fair value revaluation of warrants issued in May 2025 financing
HIGHER SHARE-BASED PAYMENTS - Co reported £10 mln in share-based payment expenses for the yr, up from £1.6 mln in 2024
INCREASED PROFESSIONAL FEES - Co incurred £1.4 mln in professional fees related to the issue of warrants in 2025

Company press release: ID:nGNX6gXFY6

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 EPS		GBP 0
Q4 Net Income		-GBP 2.49 mln
Q4 Operating Income		-GBP 2.80 mln
Q4 Pretax Profit		-GBP 2.63 mln

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

What Is Palantir? Can Palantir’s Stock Price Return to $200 in 2026?

TradingKey - In today’s highly competitive technology landscape, Palantir (PLTR), as a company with a core focus on big data and artificial intelligence, has garnered widespread attention through its unique technological advantages and market positioning.

Micron Plunges 10%, Earnings Beat Expectations, Stock Price Falls 30% Consecutively, Can AI Memory Chips Still Be Bought?

TradingKey — Micron Technology’s (MU) recent stock price performance has become a microcosm of shifting sentiment within the AI memory sector. Despite reporting robust earnings, the stock has weakened steadily following the announcement, marking a cumulative decline of nearly 30%. The market is now

IREN, NBIS, and CRWV: The Rise of Neoclouds in the AI Infrastructure Boom

Iris Energy (IREN), Nebius (NBIS) and Coreweave (CRWV) are frequently grouped due to their shared focus on AI infrastructure

Hedge Fund Tycoon Calls ‘Ten-Fold Opportunity,’ Fannie and Freddie Shares Both Surge Over 45%.

TradingKey - During Monday's U.S. Eastern trading session, shares of U.S. mortgage giants Fannie Mae and Freddie Mac experienced a rare surge, boosted by public bullish comments from renowned hedge fund manager Bill Ackman. Fannie Mae (FNMA) shares soared by more than 50%, while Freddie Mac (FMCC) jumped approximately 47%, becoming the focus of the market.

Bitcoin Price Analysis: What Is to Stop BTC from Making Another Run at All-Time Highs in 2026?

This strategic analysis covers institutional BTC price targets from JPMorgan and Fidelity, the impact of the U.S. Strategic Reserve, and whether the four-year cycle is broken. Stay updated on BTC to USD trends and key market risks.

Tradingkey

KeyAI

